3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
9
Neoplasms
7
Agnosia
5
Multiple Myeloma
4
Hodgkin Disease
4
Pain, Postoperative
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Cancer Pain
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Philadelphia Chromosome
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Carcinoma in Situ
2
Burkitt Lymphoma
2
Acute Pain
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Interventions
pegfilgrastim
3
liposomal amphotericin B
2
Vancomycin
2
Filgrastim
2
Caspofungin
2
trametinib
1
ofatumumab
1
dabrafenib
1
Teicoplanin
1
Tazobactam
1
Surveys and Questionnaires
1
Ritonavir
1
Quality of Life
1
Povidone-Iodine
1
Piperacillin, Tazobactam Drug Combination
1
Piperacillin
1
Metformin
1
Meropenem
1
Lenalidomide
1
Itraconazole
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Granulocyte Colony-Stimulating Factor
1
Doxorubicin
1
Docetaxel
1
Daptomycin
1
Cyclophosphamide
1
Cloxacillin
1
Cilastatin, Imipenem Drug Combination
1
Ceftazidime
1
Cefepime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Fever
×
Acetaminophen
×
Clear all
NCT01070732
2010-02-18
APOTEL01
University of Athens
Phase 4
Completed
100 enrolled